Consensus GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London S.E. Other stock markets 11:35:16 2024-06-06 am EDT			5-day change	1st Jan Change
1,640 ^GBX	-0.64%		-5.20%	+13.09%

06:08pm	GSK Closes Up to $50 Million Purchase of US-based Elsie Biotechnologies	MT
04:22pm	GSK: acquisition of US biotech Elsie	CF

Evolution of the average Target Price on GSK plc

Price target over the last 5 years

History of analyst recommendation changes

f47e2f613b41771ea1845d256d2ce.3OVh0f3uSQVJwogYFSJztV7UpcnuyL9zTAiH4n6BS34.n6gL4b6le0AEtv5aJhAe5gqs5KGkqfobAXH20AfJfxPsrVaUidsnWiyD0Q~dcebbe62660f5d8ef5000a74a248f89e

Analyst Recommendations on GSK plc

HSBC Lifts GSK PT, Maintains Reduce Rating	Jun. 05	MT
Berenberg raises Taylor Wimpey to 'buy'	Jun. 05	AN
GSK : DZ Bank remains Neutral	Jun. 04	ZD
GSK PLC : Frightened markets create an entry opportunity in GSK	Jun. 04
GSK : Receives a Buy rating from UBS	Jun. 04	ZD
GSK : Receives a Buy rating from Deutsche Bank	Jun. 04	ZD
ANALYST RECOMMENDATIONS : Kinder Morgan, Marathon Petroleum, Autodesk, Cloudflare, Okta...	Jun. 04
GSK : Buy rating from Jefferies	Jun. 03	ZD
GSK : Sell rating from JP Morgan	Jun. 03	ZD
GSK : Deutsche Bank reiterates its Buy rating	Jun. 03	ZD
GSK : Goldman Sachs remains Neutral	Jun. 03	ZD
Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target	May. 30	MT
Goldman Sachs Initiates GlaxoSmithKline with Neutral Rating	May. 30	MT
Jefferies and UBS cut Anglo American	May. 30	AN
GSK : Upgraded to Neutral by Goldman Sachs	May. 30	ZD
GSK executive buys GBP20,026 worth shares	May. 20	AN
GSK: FOLLOWING SETTLEMENT OF PLACING, GSK WILL HAVE FULLY EXITED…	May. 17	RE
LBBW Raises GSK PT, Reiterates Buy Rating	May. 14	MT
DB and Berenberg raise Diploma price target	May. 14	AN
Jefferies Keeps GSK at Buy, Lifts PT	May. 13	MT
GSK : Deutsche Bank maintains a Buy rating	May. 13	ZD
GSK : Receives a Buy rating from Jefferies	May. 13	ZD
BAE Systems and Mondi cut to 'neutral'	May. 13	AN
GSK : Receives a Buy rating from Bernstein	May. 08	ZD
Bernstein Lifts GSK PT, Keeps Outperform Rating	May. 08	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

16.5 GBP

Average target price

20.36 GBP

Spread / Average Target

+23.38%

High Price Target

34.79 GBP

Spread / Highest target

+110.77%

Low Price Target

14.2 GBP

Spread / Lowest Target

-13.97%

Consensus detail

Consensus revision (last 18 months)

Analysts covering GSK plc

HSBC
alphavalue	Abhishek Raval
DZ BANK	Elmar Kraus
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
JPMORGAN	James Gordon
UBS	Jo Walton
JEFFERIES	Peter Welford
GOLDMAN SACHS	Rajan Sharma
LBBW
Jefferies & Co.
Bernstein
BERNSTEIN RESEARCH	Justin Smith
Barclays
BERENBERG	Kerry Holford
Guggenheim
Citigroup
Deutsche Bank Securities
Morgan Stanley
Berenberg Bank
CREDIT SUISSE	Dominic Lunn
Bank of America Securities/Merrill Lynch
Stifel Nicolaus
ODDO BHF
Societe Generale
Liberum Capital
J.P. Morgan Chase
DEUTSCHE BANK	Emmanuel Papadakis
KEPLER CHEUVREUX	David Evans
BAADER BANK
SVB Leerink
BANK OF AMERICA (BOFA)	Graham Parry

Ratings for GSK plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar